Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Reexamination Certificate
2006-08-15
2006-08-15
Salimi, Ali R. (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
C424S202100, C424S201100, C424S816000, C435S235100
Reexamination Certificate
active
07090854
ABSTRACT:
The present invention provides a new antigenic type of chicken anaemia viruses (CAV). The CAV according to this invention is isolatable from turkeys in the field and its virulence for chickens is significantly reduced. This property makes these viruses particularly suited for preparing a live vaccine for protecting poultry against disease conditions resulting from CAV infection.
REFERENCES:
patent: 5728569 (1998-03-01), Schrier
patent: 5914113 (1999-06-01), Schrier
patent: 6723324 (2004-04-01), Schrier et al.
patent: 0 533 294 (1993-03-01), None
patent: 0 838 222 (1998-04-01), None
Yamaguchi et al: Journal of General Virology, 2000, 82, 1233-1238.
Immunology, Harper and Row, 1980, pp. 291-295.
Jagt Henricus Johannes Maria
Schrier Carla Christina
Akzo Nobel N.V.
Blackstone William M.
Ramey III William P.
Salimi Ali R.
Schwartz Aaron L.
LandOfFree
Chicken anaemia viruses of low pathogenicity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chicken anaemia viruses of low pathogenicity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chicken anaemia viruses of low pathogenicity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3640334